Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Intraocular pressure, ocular toxicity and neurotoxicity after administration of Cannabinol or Cannabigerol
Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
